Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Biliary Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Maplewood

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Maplewood

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)

  • Details

ClinicalTrials.gov ID: NCT02954991
Diagnosis Type: NSCLC
USOR Number: 17039

  • Practice Details

1580 Beam Avenue
Maplewood, Minnesota 55109
565.40 mi. away
P: (651) 779-7978

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

20190009: A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects with Mutated KRAS p.G12C

  • Details

ClinicalTrials.gov ID: NCT04303780
Diagnosis Type: NA
USOR Number: 19143

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Leukemia

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number: 18168

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Bone Mets

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Kaposi's Sarcoma

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Pages